% Expired Patents = 83.3

Trademarks = 13

Forward Citations = 42

Loading Chart...

5 inventors (with patents filed for the assignee):

Robert W Sessions (5 out of 31 patents)

Alan R Kahn (5 out of 14 patents)

Roger Sessions, Legal Representative (1 out of 1 patent)

4. John J Newton, Jr (1 out of 13 patents)

5. Leslie Clemens (1 out of 1 patent)

6 patents: Sort by Forward Citations

1. 8486454 - Method of attenuating neurogenic pain (2013-07-16),

2. 8101206 - Method of attenuating swelling or inflammation (2012-01-24),

3. D636881 - Wound dressing (2011-04-26),

4. 7875294 - Method of attenuating bruise formation (2011-01-25),

5. 7709005 - Method of attenuating neurogenic swelling or neurogenic inflammation (2010-05-04),

6. 7625585 - Method of attenuating neurogenic bruise formation (2009-12-01),

Company Overview

Sessions Pharmaceuticals Inc. is a leading pharmaceutical company dedicated to improving health and well-being through innovative medications. With a focus on research and development, we strive to bring cutting-edge treatments to patients around the world. Our extensive product portfolio includes a wide range of prescription and over-the-counter medications, addressing various therapeutic areas such as cardiovascular health, pain management, and respiratory conditions. At Sessions Pharmaceuticals, we are committed to delivering high-quality products that meet the needs of healthcare professionals and patients alike.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

6 Patents

#126 in Fort Worth, TX

#2,905 in Texas

#44,981 in US

Fort Worth, TX, United States of America

Sessions Pharmaceuticals Inc.

Forward Citations = 42

5 inventors:

Robert W Sessions (5 out of 31 patents)

Alan R Kahn (5 out of 14 patents)

Roger Sessions, Legal Representative (1 out of 1 patent)

4. John J Newton, Jr (1 out of 13 patents)

5. Leslie Clemens (1 out of 1 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Sessions Pharmaceuticals Inc.. Retrieved from https://idiyas.com/company/sessions-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]